Home/SEC 13D/G/CRNXSEC 13D/G$CRNX SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks Simplified$CRNX$83.75▲ 79.30% YTDHealthcareAug 3, 2026 · ThinkSabio BlogSEC Filing Update: #CRNX : $83.75 Sector: Healthcare | YTD: 🔼+ 79.30% The SEC disclosed Today (03-AUG-2026) that FARALLON CAPITAL MANAGEMENT LLC has INCREASED #CRNX Shares by 7.81% 🟢 * Previous Holdings: 8.34M Shares * Current Holdings: 8.99M Shares * Increase+651.00K * Increased(%)+7.81% * Ownership: 8.5% * Estimated Investment Value: $54.52M https://www.thinksabio.com/reports/isr/CRNX Institutional ownership in #CRNX has been steadily rising over the past 12 quarters in Shares: Q4 2023: 70.66M Q1 2024: 80.41M Q2 2024: 82.47M Q3 2024: 84.51M Q4 2024: 99.68M Q1 2025: 101.90M Q2 2025: 104.56M Q3 2025: 107.71M Q4 2025: 111.61M Q1 2026: 122.74M The quarterly average prices of #CRNX: Q3 2025: $31.98 Q4 2025: $44.47 Q1 2026: $44.65 Share this post🔗Copy LinkMore filings for $CRNXCRNX - Crinetics Pharmaceuticals, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026CRNX - Crinetics Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G